Ananda Pharma Plc (AQU:ANA)
London · Delayed Price · Currency is GBP · Price in GBX 0.2750
0.00 (0.00%)
At close: Oct 1, 2025
Ananda Pharma Revenue
In the fiscal year ending January 31, 2025, Ananda Pharma had annual revenue of 62.00 GBP. Ananda Pharma had revenue of -702.00 in the half year ending January 31, 2025.
Revenue
62.00
Revenue Growth
n/a
P/S Ratio
190,687.95
Revenue / Employee
6.89
Employees
9
Market Cap
11.82M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jan 31, 2025 | 62.00 | - | - |
| Jan 31, 2024 | - | - | - |
| Jan 31, 2023 | - | - | - |
| Jan 31, 2022 | - | - | - |
| Jan 31, 2021 | - | - | - |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HSBC Holdings | 41.03B |
| AstraZeneca | 41.24B |
| Shell | 198.54B |
| Unilever | 51.24B |
| Rolls-Royce Holdings | 19.54B |
| British American Tobacco p.l.c. | 25.60B |
| Rio Tinto Group | 39.22B |
| BP p.l.c. | 134.89B |